BCL2 and esophageal cancer: Regarding this, it is believed that flavopiridol promotes Bax and inhibits Bcl-2, thereby promoting caspase-3 and resulting in apoptosis and G2/M arrest in the esophageal cancer cell line, Eca109 (26).